Back to Journals » Cancer Management and Research » Volume 14

Feasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study

Total article views   HTML views PDF downloads Totals
3,743 Dovepress* 3,667+ 134 3,801
PubMed Central* 76 56 132
Totals 3,743 190 3,933
*Since 2 September 2022

View citations on PubMed Central and Google Scholar